KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPension (IS)Profit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Pitney Bowes (PBI) Research & Development (2016 - 2025)

Pitney Bowes (PBI) has disclosed Research & Development for 17 consecutive years, with $3.5 million as the latest value for Q4 2025.

  • On a quarterly basis, Research & Development fell 63.07% to $3.5 million in Q4 2025 year-over-year; TTM through Dec 2025 was $15.3 million, a 52.19% decrease, with the full-year FY2025 number at $15.3 million, down 52.19% from a year prior.
  • Research & Development was $3.5 million for Q4 2025 at Pitney Bowes, up from $3.4 million in the prior quarter.
  • In the past five years, Research & Development ranged from a high of $13.8 million in Q4 2021 to a low of $613000.0 in Q3 2023.
  • A 5-year average of $7.9 million and a median of $8.8 million in 2023 define the central range for Research & Development.
  • Peak YoY movement for Research & Development: plummeted 93.75% in 2023, then surged 1136.54% in 2024.
  • Pitney Bowes' Research & Development stood at $13.8 million in 2021, then plummeted by 77.77% to $3.1 million in 2022, then skyrocketed by 164.56% to $8.1 million in 2023, then grew by 17.1% to $9.5 million in 2024, then tumbled by 63.07% to $3.5 million in 2025.
  • Per Business Quant, the three most recent readings for PBI's Research & Development are $3.5 million (Q4 2025), $3.4 million (Q3 2025), and $3.6 million (Q2 2025).